Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jan;44(1):1-9.
doi: 10.1016/j.vph.2005.09.003. Epub 2005 Nov 7.

Plasminogen Activators: A Comparison

Affiliations
Review

Plasminogen Activators: A Comparison

Dev B Baruah et al. Vascul Pharmacol. .

Abstract

Thrombolytic drugs play a crucial role in the management of patients with acute myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis, acute thrombosis of retinal vessel, extensive coronary emboli, and peripheral vascular thromboembolism. Recognition of the importance of fibrinolytic system in thrombus resolution has resulted in the development of different fibrinolytic agents. Now a days several newer plasminogen activators with different pharmacokinetic and pharmacodynamic properties have been developed to treat thrombotic disease, which are fibrin specific with prolonged half-life and can be administered as a single bolus.

Similar articles

See all similar articles

Cited by 36 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback